Viking Therapeutics shares jump on maintenance study top-line results
Viking Therapeutics said it has positive top-line results from a maintenance study of its weight-loss drug; the stock rose 39% to $41.85 in premarket on Tuesday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.